DOCS vs TEM
DOCS: Doximity operates the leading professional network for U.S. physicians, providing a digital platform that streamlines clinical workflows and connects healthcare providers with commercial and career opportunities. TEM: Tempus AI leverages genomic sequencing, clinical data aggregation, and machine learning to deliver precision oncology diagnostics and AI-powered treatment recommendations that guide cancer patient care.
Side-by-side fundamentals
| Metric | DOCS | TEM | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $20.99 | $44.29 | |
| Market cap as of 2026-07-31 | $3.9B | $8.0B | |
| P/E as of 2026-07-31 | 19.83 | n/a | |
| Net margin as of 2026-07-31 | +30.4% | -22.2% | DOCS higher |
| Gross margin as of 2026-07-31 | +89.1% | +63.4% | DOCS higher |
| Operating margin as of 2026-07-31 | +33.3% | -20.6% | DOCS higher |
| ROE as of 2026-07-31 | +19.4% | -70.2% | DOCS higher |
| ROA as of 2026-07-31 | +16.5% | -14.6% | DOCS higher |
| Debt / equity as of 2026-07-31 | 0.00 | 2.96 | DOCS lower |
| Revenue growth (YoY) as of 2026-07-31 | +13.1% | +69.8% | TEM higher |
| Revenue CAGR (3y) SEC XBRL | +15.5% | +58.3% | TEM higher |
| Beta as of 2026-07-31 | 1.20 | 2.70 | |
| 1-year return as of 2026-07-27 close | -65.5% | -23.4% | TEM higher |
Fundamentals: market data, as of 2026-07-31. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.